Dare bioscience press release

Author: htbd

August undefined, 2024

WebMar 30, 2024 · SAN DIEGO, March 30, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31, 2024 and provided a company update. WebOct 28, 2024 · SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, and Strategic Science & Technologies, LLC (SST), a Cambridge, MA based novel topical drug delivery company, today announced a poster presentation at the Sexual Medicine Society of North America …

Press Release

WebMar 24, 2024 · Daré Bioscience Announces Interim Analysis of Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder. … Web11-50 Employees. Based in San Diego, California. Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to … earth 316

Scrip Asks…What Does 2024 Hold For Biopharma? Part 8: …

WebMar 31, 2024 · PharmaVoice: Leaders wave a magic wand at pharma’s thorniest issues WebJul 23, 2024 · We are accelerating innovation in women’s health. At Daré, we believe women’s health is an important therapeutic area that deserves dramatically increased … WebJan 9, 2024 · Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that … This section contains both current and archived webcasts and presentations of … The Investor Relations website contains information about Daré Bioscience's … ct clerks portal

Scrip Asks…What Does 2024 Hold For Biopharma? Part 7: Clinical …

WebJun 30, 2024 · Press Release Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides a Company Update 08-09-2024 at 8:00 AM EDT PDF Version June 30, 2024: $32.1 million in cash and cash equivalents July 2024: approximately $18.0 million in cash received subsequent to quarter-end: WebNov 15, 2024 · SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it has received a grant from the Bill & Melinda Gates Foundation (the foundation) of $584,986 to support activities related to development of a vaginal thermosetting gel formulation for the … ct. clearing houseWebApr 26, 2024 · SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that data from the DARE-BVFREE Phase 3 study of DARE-BV1, a thermosetting vaginal gel for the treatment of bacterial vaginosis, will be presented at the 2024 American College of … earth 365 days

"WebFeb 7, 2024 · Press Release Daré Bioscience to Participate in Upcoming Conferences. 02-07-2024 at 8:00 AM EST. PDF Version. SAN DIEGO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, ... " - Dare bioscience press release

Dare bioscience press release

Daré Bioscience Announces the Presentation of DARE-BVFREE …

WebMar 17, 2024 · Scrip Asks…What Does 2024 Hold For Biopharma? Part 8: Therapeutic Area Advances (Subscription required) WebMar 29, 2024 · Scrip Asks…What Does 2024 Hold For Biopharma? Part 10: Diversity, Equity And Inclusion (Subscription required)

Did you know?

WebDec 7, 2024 · SAN DIEGO, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA)... WebFeb 5, 2024 · SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will present at the BIO CEO & Investor Conference on Tuesday, February 11, 2024, at 11:00 a.m. Eastern Time at the …

WebJul 26, 2024 · SAN DIEGO, July 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that David Friend, PhD, the company’s Chief Scientific Officer, will present data from preclinical and clinical studies related to DARE-BV1 at the 2024 Controlled Release Society (CRS) … WebJan 6, 2024 · PharmaVoice: What’s top of mind for industry execs at JPM? January 6, 2024 / in News / by jrobison.

WebMar 30, 2024 · Daré Bioscience, Inc. filed its 10-K on Mar 30, 2024 for the period ending Dec 31, 2024. ... Press Releases. Security Transactions. Earnings reports. New markets. New products. Corporate strategies. ... Dare Bioscience, Inc. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) ... WebApr 28, 2024 · SAN DIEGO, April 28, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, President and Chief Executive Officer, will participate in a panel discussion during the Infectious Disease Virtual Conference presented by Maxim Group …

WebMar 23, 2024 · SAN DIEGO, March 23, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced that it will host a conference call and live webcast...

WebFeb 13, 2024 · SAN DIEGO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE) today announced the pricing of its previously announced underwritten public offering of 5.0 million shares of its common stock and warrants to purchase up to 3.5 million shares of its common stock. earth-33WebMar 27, 2024 · San Diego Business Journal: Sabrina Martucci Johnson, Daré's President and CEO, Named as of San Diego’s Top 50 Most Influential Women Over 50 earth 36 dcWebMar 30, 2024 · Dare Bioscience press release ( NASDAQ: DARE ): FY GAAP EPS of -$0.37 misses by $0.07. Revenue of $10M in-line. Cash and cash equivalents: $34.7 million at December 31, 2024, compared to $51.7... earth 33 marvelWebDec 31, 2024 · SAN DIEGO, March 23, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, March 30, 2024, to review its financial results for the year ended December 31, 2024 and to provide … ctc lending termWebJan 13, 2024 · Press Release Bayer and Daré Bioscience Announce Exclusive Licensing Agreement for U.S. Commercial Rights to Ovaprene ®, an Investigational Hormone … ct clerk courtWebFeb 28, 2024 · Scrip Asks…What Does 2024 Hold For Biopharma? Part 7: Clinical Trial Trends (Subscription required) earth 33 dc ct clerk office